CEINGE-Biotecnologie Avanzate Franco Salvatore | Italy
Dr. Marco Miceli is an Italian biomedical researcher with over two decades of continuous experience in molecular biology, epigenetics, genetics, and translational biomedical research, developed within leading academic and research institutions in Italy. Born on 20 February 1973, he is currently engaged at CEINGE–Biotecnologie Avanzate “Franco Salvatore” in Naples, where since October 2022 he has been working under a fixed-term collaboration contract within the national project “TASK FORCE 2022 COVID-19”. In this role, he serves as Head of the Level III Biosafety Laboratory (BSL-3), operating under the scientific supervision of Prof. Massimo Zollo, with responsibilities encompassing high-containment laboratory management, advanced virological research, and biosafety compliance. Between 2020 and 2022, Dr. Miceli worked at the University of Naples Federico II, Department of Neurosciences, Reproductive Sciences and Odontostomatology, contributing to a CDA-funded project focused on the molecular etiology of syndromic and non-syndromic genetic hearing loss, including genotype–phenotype correlations and functional characterization of pathogenic variants. His research career has been strongly rooted at CEINGE and associated institutes, where he has held multiple research appointments since 2019, collaborating on projects spanning molecular diagnostics, functional genomics, and advanced cellular models. Earlier in his career, he served as a fixed-term researcher at the IRCCS SDN Research Institute, working on innovative projects involving amniocyte stem cells, 3D scaffolds for bone tissue engineering, and epigenetic profiling of immune cells in metabolic disorders. From 2005 onward, Dr. Miceli played a sustained role in several nationally and EU-funded research programs, including EPITRON, ATLAS, APO-SYS, and PON-SIRTT-IN, primarily under the scientific guidance of Prof. Lucia Altucci. His work during this period focused on epigenetic regulation of gene expression, chromatin immunoprecipitation (ChIP), real-time PCR, histone deacetylase complexes, apoptosis regulation, and cancer epigenetics. Dr. Miceli’s long-standing expertise spans molecular genetics, chromatin biology, lentiviral systems, stem cell models, and translational biomedical research, making him a highly experienced and reliable contributor to multidisciplinary research initiatives at the interface of basic science, clinical research, and advanced biotechnological applications.
Citation Metrics (Google Scholar)
3000
2000
1000
500
400
300
200
100
50
30
10
0
Citations
Documents
h-index
View Google Scholar Profile
View Orcid Profile
Featured Publications